RELATED CONTENT
News | Artificial Intelligence
Oct. 20, 2025 — Viz.ai has launched of Viz Assist, a suite of autonomous AI agents that significantly enhance how care ...
October 20, 2025 
News | Cardiac Imaging
April 30, 2025 – Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has launched Viz ...
May 02, 2025 
News | Contrast Media
August 17, 2023 — University of Missouri School of Medicine neurologist Adnan Qureshi, MD recently led a study that ...
August 17, 2023 
July 27, 2022 — Viz.ai, a leading AI-powered disease detection and intelligent care coordination platform, announced it ...
July 27, 2022 
News | Artificial Intelligence
February 23, 2022 — Viz.ai, the world leader in artificial intelligence (AI) powered care coordination, announced it has ...
February 24, 2022 
News
July 21, 2021 — Artificial intelligence (AI) medical imaging vendors Viz.AI and Avicenna.AI have partnered to enable ...
July 21, 2021 
Feature | Artificial Intelligence | Inga Shugalo
With its increasing role in medical imaging, artificial intelligence (AI) gradually is becoming a go-to technology for ...
May 17, 2019 
Technology | Clinical Decision Support
The U.S. Food and Drug Administration (FDA) announced marketing clearance for Viz.AI’s Contact application, the first artificial intelligence (AI)-based clinical decision support (CDS) solution cleared for sale in the U.S. Viz.AI Contact is designed to analyze computed tomography (CT) results that may notify providers of a potential stroke in their patients.
February 14, 2018 